Dynamics of targeted cancer therapy
- 1 June 2012
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 18 (6) , 311-316
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- ALK Inhibition for Non-Small Cell Lung Cancer: From Discovery to Therapy in Record TimeCancer Cell, 2010
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulationNature, 2010
- Distant metastasis occurs late during the genetic evolution of pancreatic cancerNature, 2010
- Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitorOncogene, 2010
- Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLCCancer Cell, 2010
- Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: A trial of the Chicago, PMH, and California Phase II consortiaGynecologic Oncology, 2008
- Dynamics of chronic myeloid leukaemiaNature, 2005
- Targeted cancer therapyNature, 2004
- Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infectionNature, 1995
- Viral dynamics in human immunodeficiency virus type 1 infectionNature, 1995